This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Abbott Again Recognized By Science Magazine As One Of The Top Employers In The Healthcare Industry

Stocks in this article: ABT

ABBOTT PARK, Ill., Oct. 24, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today was again named one of the Top 20 Employers by the journal Science. The annual survey is based on the views of working scientists and identifies companies with the best reputations as employers.

Abbott ranked No. 18 overall, receiving high marks for social responsibility and employee loyalty. The complete rankings are available online and in the Oct. 25, 2013 print issue of Science. This is the tenth time Abbott has been ranked among the top companies in the survey.

"Abbott is first and foremost a science-driven company and we are honored by this recognition from the scientific community," said Robert H. Miller, Ph.D., Co-chair of Abbott's Scientific Governing Board, which oversees the company's 1,800 scientists. "Through cutting edge research, creativity and collaboration, our scientists have the opportunity to build rewarding careers that are redefining how we deliver healthcare to our customers."

Scientists at Abbott are given opportunities to succeed, lead and grow in their careers through training, mentoring, networking groups and development programs. In addition, a number of internal recognition efforts, including chairman's awards, president's awards and patent/inventor awards, work to highlight scientific excellence and contribution throughout the company.

The company recognizes its most distinguished scientists and engineers with induction into the prestigious Volwiler Society. Established in 1985 and named for the late Ernest H. Volwiler, Ph.D., an internationally recognized scientist and former Abbott president and chairman of the board, the society encourages professional growth and is meant to spur, recognize and showcase scientific innovation at Abbott.  Each year, the Volwiler Society issues "Outstanding Research" awards to the Abbott scientists and teams who have made significant contributions to their fields.

About the 2013 Science Survey Science's annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics. Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including financial strength, easy adaptation to change, and a research-driven environment.  The survey polled 3,656 responses with participants hailing from North America (81%), Europe (10%), and Asia/ Pacific Rim (7%); more than four out of five work in private industry.

Abbott Widely Recognized as a Great Place to WorkIn addition to being honored for workplace leadership by Science, FORTUNE has named Abbott as one of "America's Most Admired Companies" every year since the list's inception in 1983.  The company has also been named to DiversityInc magazine's list of the top companies for diversity for ten years.

About AbbottAbbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

SOURCE Abbott

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs